EUVIMEDOpdag EUVIMED
Crossref

Role of Volumetric Parameters Derived From Ga‐68 PSMA PET‐CT in Predicting Treatment Response

Ali Uyar iD, Bekir Taşdemir iD, Şadiye Altun Tuzcu iD, Zeynep Oruç iD, Halil Kömek iD

The Prostate · 2026

DOI: 10.1002/pros.70094 ↗

At a glance

Journal article in The Prostate, 2026. Written by Ali Uyar and 4 co-authors. Institution: Department of Nuclear Medicine - Bilecik, Bilecik Training and Research Hospital, Turkey. Major MEDLINE topics: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Adenocarcinoma. 15 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

We aimed to determine whether TL‐PSMA, PSMA‐TV, and SUVpeak values measured in prostate adenocarcinoma patients who underwent imaging with Ga‐68 PSMA PET/CT for primary staging have a role in predicting treatment response. Materials and Methods Images of 68 patients who underwent Ga‐68 PSMA PET/CT for primary staging between March 25, 2019, and December 3, 2021, were analyzed retrospectively. Volumetric parameter data were obtained through manual delineation using a 40% threshold for the prostate gland, lymph nodes, bone, and visceral organ metastases.

Results

TL‐PSMA(Bone) measurement differed statistically significantly between the treatment‐responsive and unresponsive groups ( p = 0.049). In addition, TL‐PSMA and PSMA‐TV parameters showed statistically significant differences between the treatment‐responsive and unresponsive groups ( p = 0.02 and p = 0.016). We could not find a significant relationship between other volumetric parameters and treatment response.

Conclusion

It has been established that the volumetric parameters derived from Ga‐68 PSMA PET/CT imaging conducted for primary staging may play a role in predicting treatment response in patients with prostate adenocarcinoma. However, further studies involving larger patient populations are necessary to clarify this issue.

Subjects

MeSH terms (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographyAdenocarcinomaHumansMaleAgedRetrospective StudiesGallium RadioisotopesMiddle AgedGallium IsotopesTreatment OutcomeAged, 80 and overNeoplasm StagingRadiopharmaceuticals

Author keywords

Ga‐68 PSMAPET/CTPSMA‐TVTL‐PSMA

Substances

Gallium RadioisotopesGallium Isotopesgallium 68 PSMA-11Radiopharmaceuticals

Authors and institutions

  • Department of Nuclear Medicine - Bilecik, Bilecik Training and Research Hospital, Turkey.
  • Department of Nuclear Medicine - Diyarbakır, Dicle University Medical Faculty, Turkey.
  • Department of Medical Oncology- Diyarbakır, Dicle University Medical Faculty, Turkey.
  • Diyarbakır Gazi Yaşargil Health Research Center, Department of Nuclear Medicine, Unıversity of Health Sciences.

ORCID profiles: Ali Uyar, Bekir Taşdemir, Şadiye Altun Tuzcu, Zeynep Oruç, Halil Kömek

Cite

APA

Uyar, A., Taşdemir, B., Tuzcu, Ş. A., Oruç, Z., & Kömek, H. (2026). Role of Volumetric Parameters Derived From Ga‐68 PSMA PET‐CT in Predicting Treatment Response. The Prostate. https://doi.org/10.1002/pros.70094

Vancouver

Uyar A, Taşdemir B, Tuzcu ŞA, Oruç Z, Kömek H. Role of Volumetric Parameters Derived From Ga‐68 PSMA PET‐CT in Predicting Treatment Response. The Prostate. 2026. doi:10.1002/pros.70094

BibTeX
@article{Uyar2026,
  author = {Uyar, Ali and Taşdemir, Bekir and Tuzcu, Şadiye Altun and Oruç, Zeynep and Kömek, Halil},
  title = {Role of Volumetric Parameters Derived From Ga‐68 PSMA PET‐CT in Predicting Treatment Response},
  journal = {The Prostate},
  year = {2026},
  doi = {10.1002/pros.70094}
}
Start for free →